SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-11-032881
Filing Date
2011-04-05
Accepted
2011-04-05 12:57:12
Documents
4
Period of Report
2011-05-12
Effectiveness Date
2011-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A g26688def14a.htm DEF 14A 752692
2 GRAPHIC g26688g2668800.gif GRAPHIC 2298
3 GRAPHIC g26688g2668801.gif GRAPHIC 1044
4 GRAPHIC g26688g2668802.gif GRAPHIC 1067
  Complete submission text file 0000950123-11-032881.txt   760255
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 11738967
SIC: 2836 Biological Products, (No Diagnostic Substances)